(688177)"Bio-Thera Solutions, Ltd."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688177 · · 3 pages · Chinese
Summary by 6ix AI
Investors can participate online through the Shanghai Stock Exchange Roadshow Center. The company aims to address common investor questions regarding its financial results during this session.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/688177bio-thera-solutions-ltdannouncement-on-convening-the-q3-2026-performance-briefing
Bio-Thera Solutions, Ltd. on 6ix
Story so far
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Signing of Energy Management Agreement for Distributed Rooftop PV Power Station between Wholly-owned Subsidiary and Related Party, and Related Party Transaction
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Re-deliberation of Energy Management Agreements and Routine Related Party Transactions
- (688177)"Bio-Thera Solutions, Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026
Earlier from Bio-Thera Solutions
- (688177)"Bio-Thera Solutions, Ltd."Report for Q3 2026
- (688177)"Bio-Thera Solutions, Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Signing of Energy Management Agreement for Distributed Rooftop PV Power Station between Wholly-owned Subsidiary and Related Party, and Related Party Transaction
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Re-deliberation of Energy Management Agreements and Routine Related Party Transactions
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Obtaining the Drug Registration Certificate for BAT2306 (Secukinumab Injection)
Later from Bio-Thera Solutions
All Bio-Thera Solutions news releasesFollow Bio-Thera Solutions into a list and get an email when it puts out news.
Follow Bio-Thera Solutions